H3 agonist immepip markedly reduces cortical histamine release, but only weakly promotes sleep in the rat

Pharmacological Research

Volumn 48, Issue 2, 2003, Pages 193-198

  Lamberty, Yves ^a   Margineanu, Doru Georg ^a   Dassesse, Donald ^a   Klitgaard, Henrik ^a  

^a UCB PHARMA   (Belgium)

Author keywords

Brain histamine; Brain microdialysis; H3 receptor; Immepip; Sleep wake cycle

Indexed keywords

HISTAMINE H3 RECEPTOR AGONIST; IMMEPIP; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DROWSINESS; DRUG EFFECT; ELECTROENCEPHALOGRAM; ELECTROMYOGRAM; HISTAMINE RELEASE; LIGHT DARK CYCLE; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; SLEEP; SLEEP WAKING CYCLE;

EID: 0037868166     PISSN: 10436618     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1043-6618(03)00094-X     Document Type: Article

References (28)

1. Lin J.S. Brain structures and mechanisms involved in the control of cortical activation and wakefulness, with emphasis on the posterior hypothalamus and histaminergic neurons. Sleep Med. Rev. 4:2000;471-503.
2. Lin J.S., Sakai K., Jouvet M. Evidence for histaminergic arousal mechanisms in the hypothalamus of cat. Neuropharmacology. 27:1988;111-122.
3. Brown R.E., Stevens D.R., Hass H.L. The physiology of brain histamine. Prog. Neurobiol. 63:2001;637-672.
4. Parmentier R., Ohtsu H., Djebbara-Hannas Z., Valatx J.L., Watanabe T., Lin J.S. Anatomical, physiology and pharmacological characteristics of histidine decarboxylase knock-out mice: evidence for the role of brain histamine in behavioral and sleep/wake control. J. Neurosci. 22:2002;7695-7711.
5. Hill S.J., Ganellin C.R., Timmerman H., Schwartz J.C., Shankley N.P., Young J.M.et al. International Union of Pharmacology. XIII. Classification of histamine receptors. Pharmacol. Rev. 49:1997;253-278.
6. Oda T., Morikawa N., Saito Y., Masuho Y., Matsumoto S. Molecular cloning and characterization of a novel type of histamine receptor preferentially expressed in leukocytes. J. Biol. Chem. 275:2000;36781-36786.
7. Arrang M., Garbag M., Schwartz J.C. Auto-inhibition of brain histamine release mediated by a novel class (H3) of histamine receptor. Nature. 302:1983;832-837.
8. 3H ]-acetylcholine from slices of rat entorhinal cortex: evidence for the possible existence of H3 receptor subtypes Br. J. Pharmacol. 107:1992;919-923.
9. Schlicker E., Malinowska B., Kathmann M., Gothert M. Modulation of neurotransmitter release via histamine H3 heteroreceptors. Fundam. Clin. Pharmacol. 8:1994;128-137.
10. Lin J.S., Sakai K., Vanni-Mercier G., Arrang J.M., Garbarg M., Schwartz J.C.et al. Involvement of histaminergic neurons in arousal mechanisms demonstrated with H3-receptor ligands in the cat. Brain Res. 523:1990;325-330.
11. Monti J.M., Jantos H., Boussard M., Altier H., Orellana C., Olivera S. Effect of selective activation or blockade of the histamine H3 receptor on sleep and wakefulness. Eur. J. Pharmacol. 205:1991;283-287.
12. Monti J.M., Jantos H., Ponzoni A., Monti D. Sleep and walking during acute histamine H3 agonist BP 2.94 or H3 antagonist carboperamide (MR 16155) administration in rats. Neuropsychopharmacology. 15:1996;31-35.
13. Lamberty Y., Neveux M., Margineanu D.G. What therapeutic potential for histaminergic H3 agonists as sedative/hypnotics? J. Affective Dis. 68:2002;122-123.
14. Rouleau A., Garbarg M., Ligneau X., Mantion C., Lavie P., Aier C.et al. J. Pharmacol. Exp. Ther. 281:1997;1085-1094.
15. Garbarg M., Arrang J.M., Rouleau A., Ligneau X., Tuong M.D., Schwartz J.C.et al. S-[2-(4-Imidazolyl)ethyl]isothiourea, a highly specific and potent histamine H3 receptor agonist. J. Pharmacol. Exp. Ther. 263:1992;304-310.
16. Corruzzi G., Gambarelli E., Bertaccini G., Timmerman H. Cardiovascular effects of selective agonists and antagonists of histamine H3 receptors in the anesthetized rat. Naunyn-Schmiedeberg's Arch. Pharmacol. 351:1995;569-575.
17. Leurs R., Tulp M.T.M., Menge W.M.B.P., Adolfs M.J.P., Zuiderveld O.P., Timmerman H. Evaluation of the receptor selectivity of H3 receptor antagonists, iodophenpropit and thioperamide: an interaction with the 5-HT3-receptor revealed. Br. J. Pharmacol. 116:1995;2315-2321.
18. 1H -imidazol-4-ylmethyl) piperidine J. Med. Chem. 37:1994;332-333.
19. 125I ]-iodophenpropit, to rat brain Br. J. Pharmacol. 113:1994;355-362.
20. Jansen F.P., Mochizuki T., Yamamoto Y., Timmerman H., Yamatodani A. In vivo modulation of rat hypothalamic histamine release by the histamine H3 receptor ligands, immepip and clobenpropit. Effect of intrahypothalamic and peripheral application. Eur. J. Pharmacol. 362:1998;149-155.
21. Mendelson W.B., Martin J.V. Effect of muscimol and flurazepam on the sleep EEG in the rat. Life Sci. 47:1990;99-101.
22. Paxinos G, Watson, C. The rat brain in stereotaxic coordinates. 2nd ed. Sydney: Academic Press; 1986.
23. Yamatodani A., Fukuda H., Wada H., Iwaeda T., Watanabe T. High-performance liquid chromatographic determination of plasma and brain histamine without previous purification of biological samples: cation-exchange chromatography coupled with post-column derivatization fluorometry. J. Chromatogr. 344:1985;115-123.
24. Mochizuki T., Yamatodani A., Okakura K., Horii A., Inagaki N., Wada H. Circadian rhythm of histamine release from the hypothalamus of freely moving rats. Physiol. Behav. 51:1992;391-394.
25. McLeod R.L., Aslanian R., Del Prado M., Duffy R., Egan R.W., Kreutner W.et al. Sch 50971, an orally active histamine H3 receptor agonist, inhibits central neurogenic vascular inflammation and produces sedation in the guinea pig. J. Pharmacol. Exp. Therap. 287:1998;43-50.
26. Tardivel-Lacombe J., Rouleau A., Heron A., Morisset S., Pillot C., Cochois V.et al. Cloning and cerebral expression of the guinea pig histamine H3 receptor: evidence for two isoforms. Neuroreport. 4:2000;755-759.
27. Ireland-Denny L., Parihar A.S., Miller T.R., Kang C.H., Krueger K.M., Esbenshade T.A.et al. Species-related pharmacological heterogeneity of histamine H3 receptors. Eur. J. Pharmacol. 433:2001;141-150.
28. Toyota H., Dugovic C., Koehl M., Laposky A., Weber C., Ngo K.et al. Behavioral characterization of mice lacking histamine H3 receptors. Mol. Pharmacol. 61:2002;389-397.